Moreover, two-step MR analyses revealed that the risk-reducing effect of HMGCR inhibition on hyperthyroidism was partially mediated by lowering the levels of insulin-like growth factor 1 (IGF-1). Here, HMGCR is linked to hyperthyroidism.